Regulatory Developments September 2019

03a_RegNews_Alternate_770x2953.jpg

FDA announces the availability of draft guidance's on Population Pharmacokinetics, eCTD Submission Requirements/Exemptions, Waivers, Advanced Prostate Cancer/Gonadotropin-Releasing Hormone Analogues Development, and more in this month's regulatory developments.

Related Stories

Table of Contents
Regulatory Developments
September 2019